N
APLT

Nuveen’s Applied Therapeutics APLT Stock Holding History

Nuveen’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-281,028
Closed -$137K – 3282
2025
Q1 		$137K Hold
281,028
– – ﹤0.01% 3183
2024
Q4 		$241K Buy
281,028
+19,608
+8% +$123K ﹤0.01% 3173
2024
Q3 		$2.22M Sell
261,420
-10,193
-4% -$60.1K ﹤0.01% 2363
2024
Q2 		$1.27M Buy
+271,613
New +$1.29M ﹤0.01% 2612
2022
Q2 		– Sell
-53,840
Closed -$98K – 3243
2022
Q1 		$98K Sell
53,840
-8,167
-13% -$21.9K ﹤0.01% 3246
2021
Q4 		$555K Sell
62,007
-12,459
-17% -$164K ﹤0.01% 3051
2021
Q3 		$1.24M Sell
74,466
-16,993
-19% -$293K ﹤0.01% 2907
2021
Q2 		$1.9M Buy
91,459
+30,380
+50% +$575K ﹤0.01% 2740
2021
Q1 		$1.15M Buy
61,079
+2,704
+5% +$58.3K ﹤0.01% 2846
2020
Q4 		$1.28M Buy
58,375
+7,386
+14% +$154K ﹤0.01% 2713
2020
Q3 		$1.06M Sell
50,989
-6,976
-12% -$181K ﹤0.01% 2662
2020
Q2 		$2.1M Buy
57,965
+20,815
+56% +$871K ﹤0.01% 2324
2020
Q1 		$1.22M Buy
37,150
+27,083
+269% +$1.1M ﹤0.01% 2422
2019
Q4 		$275K Buy
+10,067
New +$172K ﹤0.01% 3030

Other funds holding APLT

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Nuveen's APLT Position: Q2 2025 in Review

Nuveen sold out of Applied Therapeutics (APLT) in Q2 2025, closing a stake of 281,028 shares — an estimated $137K sold.

Nuveen first reported a position in APLT in Q4 2019 and held it in 14 quarters. The position peaked at $2.22M in Q3 2024. 75 funds tracked by Wall St. Rank hold APLT as of Q2 2025.

  • Nuveen reported no remaining Applied Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Nuveen sold 281,028 Applied Therapeutics shares in Q2 2025, an estimated $137K.
  • Nuveen first reported a position in Applied Therapeutics in Q4 2019 and held it in 14 quarters.
  • Nuveen's Applied Therapeutics position peaked at $2.22M in Q3 2024.
  • 75 funds tracked by Wall St. Rank held Applied Therapeutics as of Q2 2025.

Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.